ACOG supports cfDNA testing as a reasonable alternative for fetal RBC testing among alloimmunized patients MENLO PARK, Calif., July 26, 2024 /PRNewswire/ — BillionToOne, a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, is…